CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $497.89 thousand for the 98-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2013-11-14
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2013-09-30 was $151.59K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2013-06-30 was $144.09K, a 194.15% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2013-03-31 was $70.28K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2012-12-31 was $62.90K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2012 was $67.21K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2011 was -$587.56K, a 335.49% decline from fiscal 2010.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2010 was $249.50K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 71 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 74 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 77 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 80 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 83 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 86 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 89 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 92 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 95 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 98 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $151.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $295.68K derived: sum of 2 quarters · filed 2013-11-14 | $365.96K 10-Q · filed 2013-11-14 | $428.86K derived: sum of 4 quarters · filed 2013-11-14 | $497.89K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $144.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $214.37K 10-Q · filed 2013-08-14 | $277.27K derived: sum of 3 quarters · filed 2013-08-14 | $237.41K derived: sum of 4 quarters · filed 2013-11-14 | $346.30K 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $70.28K 10-Q · filed 2013-06-21 | $133.18K derived: sum of 2 quarters · filed 2013-06-21 | $93.31K derived: sum of 3 quarters · filed 2013-11-14 | $142.30K derived: sum of 4 quarters · filed 2013-11-14 | $202.20K 10-Q · filed 2013-06-21 | |||||||||
| 2012-12-31 | $62.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $23.04K derived: sum of 2 quarters · filed 2013-11-14 | $72.03K derived: sum of 3 quarters · filed 2013-11-14 | $67.21K 10-K · filed 2013-06-21 | $131.93K 10-K · filed 2013-06-21 | |||||||||
| 2012-09-30 | -$39.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $9.13K derived: sum of 2 quarters · filed 2013-11-14 | $4.31K 10-Q · filed 2013-11-14 | -$108.29K derived: sum of 4 quarters · filed 2013-11-14 | $69.03K 10-Q · filed 2013-06-21 | |||||||||
| 2012-06-30 | $48.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $44.17K 10-Q · filed 2013-08-14 | -$68.43K derived: sum of 3 quarters · filed 2013-08-14 | -$52.26K derived: sum of 4 quarters · filed 2013-08-14 | $108.89K 10-Q/A · filed 2012-09-10 | |||||||||
| 2012-03-31 | -$4.82K 10-Q · filed 2013-06-21 | -$117.42K derived: sum of 2 quarters · filed 2013-06-21 | -$101.24K derived: sum of 3 quarters · filed 2013-06-21 | -$121.37K derived: sum of 4 quarters · filed 2013-06-21 | $59.90K 10-Q/A · filed 2012-05-15 | |||||||||
| 2011-12-31 | -$112.60K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | -$96.42K derived: sum of 2 quarters · filed 2013-06-21 | -$116.56K derived: sum of 3 quarters · filed 2013-06-21 | -$587.56K 10-K · filed 2013-06-21 | $64.72K 10-K · filed 2012-04-02 | |||||||||
| 2011-09-30 | $16.17K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-06-21 | -$3.96K derived: sum of 2 quarters · filed 2013-06-21 | -$474.96K 10-Q · filed 2013-06-21 | -$660.64K derived: sum of 4 quarters · filed 2013-06-21 | $177.32K 10-Q · filed 2011-11-14 | |||||||||
| 2011-06-30 | -$20.13K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-10 | -$491.13K 10-Q/A · filed 2012-09-10 | -$676.81K derived: sum of 3 quarters · filed 2012-09-10 | -$755.66K derived: sum of 4 quarters · filed 2012-09-10 | $161.14K 10-Q · filed 2011-08-15 | |||||||||
| 2011-03-31 | -$471.00K 10-Q/A · filed 2012-05-15 | -$656.68K derived: sum of 2 quarters · filed 2012-05-15 | -$735.53K derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||
| 2010-12-31 | -$185.68K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02 | -$264.53K derived: sum of 2 quarters · filed 2012-04-02 | $249.50K 10-K · filed 2012-04-02 | |||||||||||
| 2010-09-30 | -$78.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $435.19K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $514.04K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |